KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Acquisitions (2016 - 2024)

Charles River Laboratories International has reported Acquisitions over the past 14 years, most recently at $5.5 million for Q2 2024.

  • For Q2 2024, Acquisitions changed N/A year-over-year to $5.5 million; the TTM value through Sep 2025 reached $5.5 million, down 96.35%, while the annual FY2024 figure was $5.5 million, 97.19% down from the prior year.
  • Acquisitions for Q2 2024 was $5.5 million at Charles River Laboratories International, down from $144.6 million in the prior quarter.
  • Over five years, Acquisitions peaked at $906.3 million in Q2 2021 and troughed at -$518000.0 in Q4 2020.
  • A 5-year average of $199.6 million and a median of $94.2 million in 2021 define the central range for Acquisitions.
  • On a YoY basis, Acquisitions climbed as much as 38550.15% in 2020 and fell as far as 1059.26% in 2020.
  • Year by year, Acquisitions stood at -$518000.0 in 2020, then surged by 293.44% to $1.0 million in 2021, then skyrocketed by 28182.63% to $283.4 million in 2022, then tumbled by 48.97% to $144.6 million in 2023, then crashed by 96.21% to $5.5 million in 2024.
  • Business Quant data shows Acquisitions for CRL at $5.5 million in Q2 2024, $144.6 million in Q4 2023, and $50.2 million in Q2 2023.